Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Chini M et al. Effects of HAART on platelet-activating factor metabolism in naive HIV-infected patients I: study of the tenofovir-DF/emtricitabine/efavirenz HAART regimen. 2012 AIDS Res. Hum. Retroviruses pmid:22050695
Nordin N et al. Platelet-activating factor (PAF) receptor binding activity of the roots of Enicosanthellum pulchrum. 2012 Pharm Biol pmid:22103812
Tanaka Y et al. Stimulation of Ly-6G on neutrophils in LPS-primed mice induces platelet-activating factor (PAF)-mediated anaphylaxis-like shock. 2012 J. Leukoc. Biol. pmid:22131343
Shi W et al. The nondepolarizing, normokalemic cardioplegia formulation adenosine-lidocaine (adenocaine) exerts anti-neutrophil effects by synergistic actions of its components. 2012 J. Thorac. Cardiovasc. Surg. pmid:22079877
Detopoulou P et al. PAF and its metabolic enzymes in healthy volunteers: interrelations and correlations with basic characteristics. 2012 Prostaglandins Other Lipid Mediat. pmid:22079887
Ding DD et al. [Changes of platelet α-particle membrane protein, platelet activating factor and platelet parameters in patients with hyperuricemia]. 2012 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:22541106
Camuesco D et al. The intestinal anti-inflammatory effect of dersalazine sodium is related to a down-regulation in IL-17 production in experimental models of rodent colitis. 2012 Br. J. Pharmacol. pmid:21790535
Sahu RP et al. The environmental stressor ultraviolet B radiation inhibits murine antitumor immunity through its ability to generate platelet-activating factor agonists. 2012 Carcinogenesis pmid:22542595
Sato A et al. Synthetic biotinylated peptide compounds derived from Asp-hemolysin: novel potent inhibitors of platelet-activating factor. 2012 Eur. J. Pharmacol. pmid:22542654
Bachi AL et al. Apoptotic cells contribute to melanoma progression and this effect is partially mediated by the platelet-activating factor receptor. 2012 Mediators Inflamm. pmid:22577252
Neerhof MG et al. The significance of endothelin in platelet-activating factor-induced fetal growth restriction. 2012 Reprod Sci pmid:22534337
Samapati R et al. Lung endothelial Ca2+ and permeability response to platelet-activating factor is mediated by acid sphingomyelinase and transient receptor potential classical 6. 2012 Am. J. Respir. Crit. Care Med. pmid:22246702
Yao Y et al. Platelet-activating factor receptor agonists mediate xeroderma pigmentosum A photosensitivity. 2012 J. Biol. Chem. pmid:22303003
Du Y et al. Macrophage VLDL receptor promotes PAFAH secretion in mother's milk and suppresses systemic inflammation in nursing neonates. 2012 Nat Commun pmid:22910354
Jalil J et al. Platelet-activating factor (PAF) antagonistic activity of a new biflavonoid from Garcinia nervosa var. pubescens King. 2012 Molecules pmid:22964504
Kakazu A et al. Lipoxin Aâ‚„ inhibits platelet-activating factor inflammatory response and stimulates corneal wound healing of injuries that compromise the stroma. 2012 Exp. Eye Res. pmid:22828048
Uomo G Lesson from acute experimental pancreatitis: multidrug strategies is effective than single-target therapy. 2012 JOP pmid:22964964
Huang LG et al. [Effects of glycomacropeptide on damage to intestinal tissue and apoptosis of intestinal epithelial cells in neonatal rats with necrotizing enterocolitis]. 2012 Zhonghua Er Ke Za Zhi pmid:22932017
Pawlowic MC and Zhang K Leishmania parasites possess a platelet-activating factor acetylhydrolase important for virulence. 2012 Mol. Biochem. Parasitol. pmid:22954769
Nitoda E et al. Ocular actions of platelet-activating factor: clinical implications. 2012 Expert Opin. Ther. Targets pmid:22924390
Conejeros I et al. 2-Aminoethoxydiphenyl borate (2-APB) reduces respiratory burst, MMP-9 release and CD11b expression, and increases l-selectin shedding in bovine neutrophils. 2012 Res. Vet. Sci. pmid:21071047
Sahu RP et al. Loss of the platelet activating factor receptor in mice augments PMA-induced inflammation and cutaneous chemical carcinogenesis. 2012 Carcinogenesis pmid:22223848
Conejeros I et al. 2-Aminoethoxydiphenyl borate (2-APB) reduces alkaline phosphatase release, CD63 expression, F-actin polymerization and chemotaxis without affecting the phagocytosis activity in bovine neutrophils. 2012 Vet. Immunol. Immunopathol. pmid:22226550
Dumas E et al. Angiopoietin-1 but not angiopoietin-2 promotes neutrophil viability: Role of interleukin-8 and platelet-activating factor. 2012 Biochim. Biophys. Acta pmid:22198097
López-Sagaseta J et al. sPLA2-V inhibits EPCR anticoagulant and antiapoptotic properties by accommodating lysophosphatidylcholine or PAF in the hydrophobic groove. 2012 Blood pmid:22167755
Park J et al. Females with angina pectoris have altered lipoprotein metabolism with elevated cholesteryl ester transfer protein activity and impaired high-density lipoproteins-associated antioxidant enzymes. 2012 Int. J. Mol. Med. pmid:22211242
Bae R et al. Albuterol isomers modulate platelet-activating factor synthesis and receptor signaling in human bronchial smooth muscle cells. 2012 Int. Arch. Allergy Immunol. pmid:22212397
Widgerow AD and Kalaria S Pain mediators and wound healing--establishing the connection. 2012 Burns pmid:22738827
Altomare A et al. Platelet-activating factor and distinct chemokines are elevated in mucosal biopsies of erosive compared with non-erosive reflux disease patients and controls. 2012 Neurogastroenterol. Motil. pmid:22734465
Iyú D et al. The role of prostanoid receptors in mediating the effects of PGE3 on human platelet function. 2012 Thromb. Haemost. pmid:22318645
Xu LF et al. Protective effect of intestinal trefoil factor on injury of intestinal epithelial tight junction induced by platelet activating factor. 2012 Inflammation pmid:21452036
Bai J et al. Sesquiterpenes from the roots of Illicium dunnianum. 2012 Phytochemistry pmid:22695122
Carosati E et al. 1,4-Dihydropyridine scaffold in medicinal chemistry, the story so far and perspectives (part 2): action in other targets and antitargets. 2012 Curr. Med. Chem. pmid:22709009
Harpavat S et al. Novel treatments for NEC: keeping IBD in mind. 2012 Curr Gastroenterol Rep pmid:22623180
Flasiński M et al. Behavior of platelet activating factor in membrane-mimicking environment. Langmuir monolayer study complemented with grazing incidence X-ray diffraction and Brewster angle microscopy. 2012 J Phys Chem B pmid:22834697
Yuan D and He P Vascular remodeling alters adhesion protein and cytoskeleton reactions to inflammatory stimuli resulting in enhanced permeability increases in rat venules. 2012 J. Appl. Physiol. pmid:22837164
Gorman S and Hart PH The current state of play of rodent models to study the role of vitamin D in UV-induced immunomodulation. 2012 Photochem. Photobiol. Sci. pmid:22898802
Zhang XT et al. [Study on the pharmacokinetics of ginkgolide B for injection in rats]. 2012 Zhong Yao Cai pmid:22876684
Flamm MH et al. Multiscale prediction of patient-specific platelet function under flow. 2012 Blood pmid:22517902
Mirpuri J et al. Lactobacillus rhamnosus (LGG) regulates IL-10 signaling in the developing murine colon through upregulation of the IL-10R2 receptor subunit. 2012 PLoS ONE pmid:23272193
Kim HA et al. PTEN/MAPK pathways play a key role in platelet-activating factor-induced experimental pulmonary tumor metastasis. 2012 FEBS Lett. pmid:23137704
Jiang Z et al. The effect of lipoprotein-associated phospholipase A2 deficiency on pulmonary allergic responses in Aspergillus fumigatus sensitized mice. 2012 Respir. Res. pmid:23140447
Senbagavalli P et al. Immune complexes isolated from patients with pulmonary tuberculosis modulate the activation and function of normal granulocytes. 2012 Clin. Vaccine Immunol. pmid:23100480
Zhang J et al. Traumatic brain injury-associated coagulopathy. 2012 J. Neurotrauma pmid:23020190
Zia-Ul-Haq M et al. Report: Platelet aggregation inhibition activity of selected legumes of Pakistan. 2012 Pak J Pharm Sci pmid:23010006
Petho G and Reeh PW Sensory and signaling mechanisms of bradykinin, eicosanoids, platelet-activating factor, and nitric oxide in peripheral nociceptors. 2012 Physiol. Rev. pmid:23073630
Tsoupras AB et al. Platelet-activating factor and its basic metabolic enzymes in blood of naive HIV-infected patients. 2012 Angiology pmid:21948973
Juchem G et al. Regulation of coronary venular barrier function by blood borne inflammatory mediators and pharmacological tools: insights from novel microvascular wall models. 2012 Am. J. Physiol. Heart Circ. Physiol. pmid:22081707
Saadawi S et al. Inhibitory effects of acetylmelodorinol, chrysin and polycarpol from Mitrella kentii on prostaglandin Eâ‚‚ and Thromboxane Bâ‚‚ production and platelet activating factor receptor binding. 2012 Molecules pmid:22538486
Oh SF et al. Resolvin E2 formation and impact in inflammation resolution. 2012 J. Immunol. pmid:22450811